Interferon Sciences Inc. has netted $8.5 million through apublic offering of 2 million shares priced at $5 per share, theNew Brunswick, N.J., company said Wednesday. Interferonshares (NASDAQ:IFSC) closed at $7, up $1.50.

Underwriter Commonwealth Associates has an option to buy anadditional 300,000 share overallotment.

Interferon had announced in June that it would offer 1 millionshares of convertible preferred stock at $10 per share.

Interferon is developing alpha interferon-based products totreat viral diseases, cancers and immune system diseases. Thecompany sells Alferon N Injection to treat external genitalwarts.

(c) 1997 American Health Consultants. All rights reserved.